This Is Why You Don't Stand on the Sidelines

The Dow Jones Industrial Average broke 12,000 for the first time ever on Oct. 18. Since then, it's been even better -- the Dow now sits at 12,140, up nearly 12% year to date.

That's right: The index made up of 30 of the largest, most widely held stocks in the United States has cruised by the mythical 12,000 mark.

So much for all of that summertime panic!

A primer
We've written before about the powerful long-term returns the stock market offers. In fact, some readers would no doubt accuse us of beating that horse one too many times (gory as that image may be).

But it's not something to be taken for granted. Have you heard the now-famous story Warren Buffett told in an early shareholder letter? The gist of it goes like this: In 1636, the Dutch purchased the island of Manhattan for $24 worth of glass beads. In 2004, the assessed value of the island's properties was $186 billion.

That's just a 6.37% annualized return -- meaningfully less than the 10% or so the stock markets have returned over the past century, even despite economic troughs!

Stuff happens
Look, the world goes round and round, and bad things happen sometimes. Just in the past decade, the markets have been deflated by tech-stock euphoria, then deflated more by corporate corruption, and then deflated some more by geopolitical catastrophes ... yet it has bounced back each time.

Then this past May, the market fell into another one of its mood swings. And guess what? It looks to be bouncing back again.

Big companies have largely been responsible for driving the market indices up recently. That's great news for investors, many of whom own a slug of them via an index fund. See, Dow components AIG (NYSE: AIG  ) and AT&T (NYSE: T  ) are also among the largest positions in any S&P 500-tracking fund, and most investors already have a ton of exposure to that market segment. And while you'll likely do fine by sticking with large caps and index funds, you should know that you can do better.

What would you do with a dollop?
How can you do better? Well, let's clear this up right now: For the extra juice, do something Buffett can't -- think small. While you can do extensive research into valuing Dow members such as Merck (NYSE: MRK  ) and Pfizer (NYSE: PFE  ) , we don't think that one will outpace the other by anything more than a few percentage points over the next few years. In other words, the reward for your work is nominal when you can just get them both in a low-cost fund.

Peter Lynch, a man we admire very, very much, said it best in his classic One Up on Wall Street:

The size of a company has a great deal to do with what you can expect to get out of the stock. ... Specific products aside, big companies don't have big stock moves.

The spread between the best and worst small caps, on the other hand, is much, much wider.

Why small? Or, better, why small caps?
Remember the DJIA? Well, the small-cap Russell 2000 index has an even more impressive trajectory. And just take a look at some of the market's biggest gainers of the past five years.


Five-Year Return

Nov. 2001 Market Cap

Global Crossing (Nasdaq: GLBC  )


$951 million

Ultra Petroleum (AMEX: UPL  )


$443 million

Guess? (NYSE: GES  )


$243 million

Data from Capital IQ.

Those are the glitzy returns that will put your portfolio into overdrive. And what do they have in common? That's right: These stocks were all small caps when their amazing runs began.

Let's face it
We can hem and haw about which large caps are the best buys right now, but all of that work will help us do only a little bit better. If, however, we spend our time deciding which small caps are the best buys right now, maybe -- just maybe -- we'll hit on the next 20-bagger. That's the promise of small-cap investing and the reason we offer our Motley Fool Hidden Gems service to interested investors.

As Peter Lynch said, "Everything else being equal, you'll do better with the smaller companies." So if you don't have at least a little small-cap exposure, just think of how much better you could be doing.

This article was originally published on Sept. 21, 2006. It has been updated.

Tim HansonandBrian Richardsinvite you to be their guest at Hidden Gemsfree for 30 days. Justclick herefor more information. Neither Tim nor Brian owns shares of any company mentioned. Pfizer is an Inside Value recommendation. The Fool'sdisclosure policy is always Googling itself.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 511020, ~/Articles/ArticleHandler.aspx, 10/7/2015 3:04:03 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Tim Hanson

Today's Market

updated 5 hours ago Sponsored by:
DOW 16,790.19 13.76 0.08%
S&P 500 1,979.92 -7.13 -0.36%
NASD 4,748.36 -32.90 -0.69%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/6/2015 4:00 PM
AIG $57.68 Down -0.60 -1.03%
American Internati… CAPS Rating: ****
GES $21.48 Down -0.25 -1.15%
Guess? CAPS Rating: ***
GLBC.DL $0.00 Down +0.00 +0.00%
Global Crossing Lt… CAPS Rating: *
MRK $49.80 Down -1.43 -2.79%
Merck & Co., Inc. CAPS Rating: ****
PFE $32.79 Down -0.69 -2.06%
Pfizer CAPS Rating: ****
T $33.31 Down -0.12 -0.36%
AT&T CAPS Rating: ****
UPL $7.23 Up +0.39 +5.70%
Ultra Petroleum CAPS Rating: ***